🙃 Inverse Cramer Jun 11
WEDNESDAY JUN 11
I’m getting tired of the orphan drug model. I think it works for some time, I don’t think it works now.
-On BioMarin ($BMRN)
I think it’s a buy. I’m glad you highlighted it tonight because I think it’s a really good stock to own.
-On Union Pacific ($UNP)
I was prepared for disappointment and I got it. I just do not want enterprise software right now. I think they’re all too expensive.
-On Gitlab ($GTLB)
I like their model. It’s a great flier. Someone needs that technology, someone’s going to pay for it.
-On ARS Pharmaceutical ($SPRY)
It’s really really high. If it does an offering here, that’s when I’d buy. I’d wait for the stock offering after what happened with Oklo tonight.
-On Nuscale Power ($SMR)
That’s a wrap. As always, we’ll be following Cramer’s every move so you can do the opposite.
See you tomorrow,
-IC